Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase 1/2 1Phase 1 1

Status

Recruiting 2Not yet recruiting 2Completed 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 3HR+/HER2- Early Breast Cancer 1HR+/HER2+ Early Breast Cancer 1

Interventions

Specimen Handling 265Magnetic Resonance Spectroscopy 216pembrolizumab 212Carboplatin 173Biopsy 162Cisplatin 155Nivolumab 147Cyclophosphamide 131Paclitaxel 116Radiotherapy 115Gemcitabine 110Bevacizumab 91durvalumab 84Dexamethasone 79Rituximab 74Oxaliplatin 71atezolizumab 67Fluorouracil 66Doxorubicin 65Capecitabine 65Docetaxel 64venetoclax 63Etoposide 63Radiosurgery 58Radiation 57Prednisone 55Ipilimumab 55Cytarabine 55Pemetrexed 54Lenalidomide 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Aromatase Inhibitors × 90 days × Clear all
NCT07616427 2026-06-01

TAYLOR-003

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting
100 enrolled
Breast

HR+/HER2+ Early Breast Cancer

NCT07616453 2026-06-01

TAYLOR-002

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting
45 enrolled
Breast

HR+/HER2- Early Breast Cancer

NCT07618923 2026-06-01

TD-DASHER-01

Tang-Du Hospital

Phase 2 Not yet recruiting
20 enrolled
Breast

Breast Neoplasms

NCT07527806 2026-04-17

Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

Peking University Cancer Hospital & Institute

Phase 2 Not yet recruiting
156 enrolled
Breast

Breast Neoplasms

NCT02630693 2026-04-13

Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer

Canadian Cancer Trials Group

Phase 2 Completed
180 enrolled 14 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡